These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36238359)

  • 1. Investigation of bone invasion and underlying mechanisms of oral cancer using a cell line-derived xenograft model.
    Shan Q; Takabatake K; Omori H; Kawai H; Oo MW; Sukegawa S; Fujii M; Inada Y; Sano S; Nakano K; Nagatsuka H
    Oncol Lett; 2022 Nov; 24(5):382. PubMed ID: 36238359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of cancer stroma for bone destruction in oral squamous cell carcinoma using different cancer stroma subtypes.
    Shan Q; Takabatake K; Kawai H; Oo MW; Inada Y; Sukegawa S; Fushimi S; Nakano K; Nagatsuka H
    Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35211756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Origin of Stroma Influences the Biological Characteristics of Oral Squamous Cell Carcinoma.
    Omori H; Shan Q; Takabatake K; Nakano K; Kawai H; Sukegawa S; Tsujigiwa H; Nagatsuka H
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal cells in the tumor microenvironment promote the progression of oral squamous cell carcinoma.
    Shan Q; Takabatake K; Omori H; Kawai H; Oo MW; Nakano K; Ibaragi S; Sasaki A; Nagatsuka H
    Int J Oncol; 2021 Sep; 59(3):. PubMed ID: 34368860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice.
    Cui N; Nomura T; Noma H; Yokoo K; Takagi R; Hashimoto S; Okamoto M; Sato M; Yu G; Guo C; Shibahala T
    Clin Cancer Res; 2005 Apr; 11(7):2713-9. PubMed ID: 15814653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of different osteoclast phenotypes in the progression of bone invasion by oral squamous cell carcinoma.
    Quan J; Hou Y; Long W; Ye S; Wang Z
    Oncol Rep; 2018 Mar; 39(3):1043-1051. PubMed ID: 29286135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells.
    Kayamori K; Sakamoto K; Nakashima T; Takayanagi H; Morita K; Omura K; Nguyen ST; Miki Y; Iimura T; Himeno A; Akashi T; Yamada-Okabe H; Ogata E; Yamaguchi A
    Am J Pathol; 2010 Feb; 176(2):968-80. PubMed ID: 20035059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption.
    Tao H; Okamoto M; Nishikawa M; Yoshikawa H; Myoui A
    PLoS One; 2011; 6(8):e23199. PubMed ID: 21886782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma.
    Martin CK; Dirksen WP; Shu ST; Werbeck JL; Thudi NK; Yamaguchi M; Wolfe TD; Heller KN; Rosol TJ
    Oral Oncol; 2012 Jun; 48(6):491-9. PubMed ID: 22265717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid-related protein plays a critical role in bone invasion by oral squamous cell carcinoma.
    Takayama Y; Mori T; Nomura T; Shibahara T; Sakamoto M
    Int J Oncol; 2010 Jun; 36(6):1387-94. PubMed ID: 20428761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Axin2-snail axis promotes bone invasion by activating cancer-associated fibroblasts in oral squamous cell carcinoma.
    An YZ; Cho E; Ling J; Zhang X
    BMC Cancer; 2020 Oct; 20(1):987. PubMed ID: 33046030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoregulation of RANK ligand in oral squamous cell carcinoma tumor cells.
    Sambandam Y; Ethiraj P; Hathaway-Schrader JD; Novince CM; Panneerselvam E; Sundaram K; Reddy SV
    J Cell Physiol; 2018 Aug; 233(8):6125-6134. PubMed ID: 29323724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid-hormone-related protein induces expression of receptor activator of NF-{kappa}B ligand in human periodontal ligament cells via a cAMP/protein kinase A-independent pathway.
    Fukushima H; Jimi E; Kajiya H; Motokawa W; Okabe K
    J Dent Res; 2005 Apr; 84(4):329-34. PubMed ID: 15790738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone inhibits the expression of membrane-type matrix metalloproteinase-1 (MT1-MMP) in osteoblast-like MG-63 cells.
    Luo XH; Liao EY; Su X; Wu XP
    J Bone Miner Metab; 2004; 22(1):19-25. PubMed ID: 14691682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of RANKL and inhibition of membrane-type matrix metalloproteinase-1 expression by parathyroid hormone in normal human osteoblasts.
    Guo LJ; Xie H; Zhou HD; Luo XH; Peng YQ; Liao EY
    Endocr Res; 2004 Aug; 30(3):369-77. PubMed ID: 15554353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion.
    Pramanik KK; Nagini S; Singh AK; Mishra P; Kashyap T; Nath N; Alam M; Rana A; Mishra R
    Cell Oncol (Dordr); 2018 Feb; 41(1):47-60. PubMed ID: 29134466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myricetin suppresses LPS-induced MMP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKL-induced RAW 264.7 cells.
    Ko SY
    Arch Oral Biol; 2012 Dec; 57(12):1623-32. PubMed ID: 22795564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
    Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
    Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synthetic triterpenoid TP-222 inhibits RANKL stimulation of osteoclastogenesis and matrix metalloproteinase-9 expression.
    Fava RA; Elliott S; Raymond L; Mollmark J; Hays E; Honda T; Gribble GW; Sporn MB; Vincenti MP
    J Rheumatol; 2007 May; 34(5):1058-68. PubMed ID: 17361985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.